Pharmacotherapy for cancer pain

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 5, Issue 6, 2005, Pages 203-206

  Oxberry, Stephen G ^a   Simpson, Karen H ^b  

^a Department of Palliative Medicine ^*  (United Kingdom)

^b SEACROFT HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 28444465853     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mki053     Document Type: Article

References (9)

1. Cleary JF. Cancer pain management. Cancer Control 2000; 7: 120-31
2. Grond S, Zech D, Diefenbach C, Radbruch L, Lehmann KA. Assessment of cancer pain: A prospective evaluation in 2266 cancer patients referred to a pain service. Pain 1996; 64: 107-114
3. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: Characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-34
4. Ventafridda V, Tamburini M, Caraceni A, De-Conno F, Naldi F. A validation study of the WHO method for cancer pain relief. Cancer 1987; 59: 850-6
5. Anonymous. Vioxx: An unequal partnership between safety and efficacy. Lancet 2004; 364: 1287-8
6. Coluzzi PH, Schwartzberg L, Conroy JD, et al. Breakthrough cancer pain: a randomised trial comparing oral fentanyl citrate (OFTC) and morphine sulphate immediate release (MSIR). Pain 2001; 91: 123-30
7. Klepstad P, Kaasa S, Jystad A, Hval B, Borchgrevink PC. Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomised, double blind trial. Pain 2003; 101: 193-8
8. Joranson DE, Ryan KM, Gilson AM, Dahl JL. Trends in medical use and abuse of opioid analgesics. JAMA 2000; 283: 1710-14
9. Moore A, Edwards J, Barden J, McQuay H. Bandolier's Little Book of Pain, 1st Edn. Oxford: Oxford University Press, 2003